KINGWORLD MEDICINES GROUP LTDKK

KINGWORLD MEDICINES GROUP LTD

0.420HKDD
0.0000.00%
At close at 06:42 GMT
HKD
No trades
See on Supercharts

1110 fundamentals

Key facts

Market capitalization‪254.73 M‬HKD
Founded1996
Employees (FY)‪1 K‬
CEO
About

Kingworld Medicines Group Ltd. is an investment holding company. It operates under the Distribution Sales of Pharmaceutical and Healthcare Products; and Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices segments. The Distribution Sales of Pharmaceutical and Healthcare Products segment focuses on distributing and selling branded imported pharmaceutical and healthcare products. The Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices segment includes manufacturing and selling electrotherapeutic and physiotherapeutic devices and general medical examination devices. The company was founded by Lok San Chan and Li Sheng Zhao in 1996 and is headquartered in Shenzhen, China.

Ownership
‪‪592.45 M‬‬
Free Float shares
‪‪474.20 M‬‬ (80.04%)
Closely held shares
‪‪118.25 M‬‬ (19.96%)
Free Float shares
‪‪474.20 M‬‬ (80.04%)
Closely held shares
‪‪118.25 M‬‬ (19.96%)
Capital structure
Market cap
‪‪254.73 M‬‬
Debt
‪‪417.36 M‬‬
Minority interest
‪‪102.32 M‬‬
Cash & equivalents
‪‪324.61 M‬‬
Enterprise value
‪‪449.80 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪254.73 M‬‬
Price to earning ratio (P/E)
7.37x
Price to sales ratio (P/S)
0.22x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
7.37x
Price to sales ratio (P/S)
0.22x
Valuation ratios
‪0.00‬
‪0.12‬
‪0.24‬
‪0.36‬
‪0.48‬
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
‪0.00‬
‪5.00‬
‪10.00‬
‪15.00‬
‪20.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−2.5%‬
‪0.0%‬
‪2.5%‬
‪5.0%‬
‪7.5%‬
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
‪‪−210.00 M‬‬
‪0.00‬
‪‪210.00 M‬‬
‪‪420.00 M‬‬
‪‪630.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬
‪‪450.00 M‬‬
‪‪600.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬
‪‪450.00 M‬‬
‪‪600.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Pharmaceutical and Healthcare
Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices
By country
Period: 2023
China
Hong Kong

Dividends

Dividend yield, history and sustainability

Dividend summary
59.30%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
8.05%
Last payment
0.034
Last ex-date
Jun 3, 2024
Dividend history
‪0.85%‬
‪2.05%‬
‪3.25%‬
‪4.45%‬
‪5.65%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.01‬
‪0.02‬
‪0.03‬
‪0.04‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
‪0.00‬
‪‪110.00 M‬‬
‪‪220.00 M‬‬
‪‪330.00 M‬‬
‪‪440.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬
‪‪1.00 B‬‬
Assets
Liabilities